Moderna President Stephen Hoge Reports Routine RSU Vest and Tax Share Withholding

Executive Summary

On September 3, 2026, Moderna, Inc. ($MRNA) filed a Form 4 disclosing transactions by President Stephen Hoge on September 1, 2026. The filing reports the vesting of 9,283 Restricted Stock Units (RSUs) and a subsequent disposition of 4,489 shares of Common Stock to satisfy mandatory tax withholding obligations.

Transaction Analysis

• RSU Conversion (Code M): 9,283 RSUs converted into Common Stock on a 1-for-1 basis at $0 per share.
• Tax Withholding (Code F): 4,489 shares were withheld by the company at a price of $140.34 per share, totaling approximately $629,986.26, to cover tax withholding liabilities associated with the vesting.
• Ownership Status: Following the reported transactions, Dr. Hoge directly owns 1,489,699 shares of Moderna Common Stock and 92,828 unvested RSUs. He also maintains indirect beneficial ownership of 4,116 shares via Valhalla, LLC and 151,933 shares through a family trust.

Market & Governance Impact

This filing reflects standard equity compensation vesting and automated/elective share withholding for taxes rather than open-market buying or discretionary selling. As a result, the market impact is considered low.